In this Point of View editorial, the Global Health Initiative's Calyn Ostrowski says more investment is needed in the developing world to improve health systems that would, in effect, help reduce maternal mortality.
Webcast: March 9, 2006featuringDr. Peter Piot, Executive Director of UNAIDS and United States Representative Jim Leach
According to the World Health Organization (WHO), approximately 800 women die daily from preventable causes related to pregnancy and childbirth. Almost all of these deaths occur in developing countries, with higher rates for women living in rural areas and among poorer communities.
Webcast: October 3, 2007featuringA Director's Forum with Robin Cook, physician, bestselling author, and Member of the Wilson Center's Board of Trustees; James Morone, Professor of Political Science and Urban Studies, Brown University; Michael Cannon, Director of Health Policy Studies, Cato Institute; and Paul Seltman, Counsel, Drinker Biddle & Reath LLP
A new study released by the Wilson Center's Project on Emerging Nanotechnologies, a project created in partnership with The Pew Charitable Trusts, reveals that while Americans welcome new potential life-saving and -enhancing applications promised by nanotechnology, they voice concern over its potential long-term human health and environmental effects and the ability of government and the private sectors to manage such risks.
On November 2, 2006, the Global Health Initiative and the Africa Program hosted a vibrant roundtable workshop on the health imperatives for Africa and the need for the public and private sectors to cooperate in the provision of health care. This publication includes a list of conclusions and next steps reached by the participants as well as summaries of the three papers commissioned for the meeting on: Africa health trends; improving health efficiencies; and, expanding public-private sector partnerships.
26 February 2008 – WHO releases new survey results on tuberculosis drug resistance. Data shows the highest rates of multidrug-resistant TB to date.